Novo hopes for European Saxenda launch this year after CHMP nod

Carly Helfand

Nordisk's obesity therapy is on a roll. Just over a month snagging FDA approval, the drug scored a positive recommendation on Thursday from Europe's Committee for Medicinal Products for Human Use (). But by the time it gets to the regulatory finish line, the med may have some competition on the continent.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS